Astria Therapeutics Inc
Change company Symbol lookup
Select an option...
ATXS Astria Therapeutics Inc
NEOV NeoVolta Inc
SCHL Scholastic Corp
SIDU Sidus Space Inc
MGY Magnolia Oil & Gas Corp
CWBR CohBar Inc
UPTDU TradeUP Acquisition Corp
BHAC Crixus BH3 Acquisition Co
ASPA Abri SPAC I Inc
WORX Scworx Corp
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Astria Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapies for patients and families affected by rare and niche allergic and immunological diseases. Its lead product candidate, STAR-0215, a potential monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema (HAE), a rare, debilitating and potentially life-threatening disease. Plasma kallikrein is an enzyme that cleaves high molecular weight kininogen (HMWK), to release bradykinin. It has four therapies for on-demand treatment of HAE: BERINERT (C1 esterase inhibitor (human)), FIRAZYR (icatibant injection), KALBITOR (ecallantide) and RUCONEST (C1 esterase inhibitor (recombinant)). Its long-term preventative treatment of HAE therapies: CINRYZE (C1 esterase inhibitor (human)), HAEGARDA (C1 esterase inhibitor subcutaneous (human)), TAKHZYRO (lanadelumab-flyo) and ORLADEYO (berotralstat).

Closing Price
$6.99
Day's Change
0.10 (1.45%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.59
Day's Low
6.85
Volume
(Heavy Day)
Volume:
212,833

10-day average volume:
111,796
212,833
  • Prev Close
    6.89
  • Today's Open
    6.85
  • Day's Range
    6.85-7.59
  • Avg Vol (10-day)
    111.8K
  • Last (time)
    4:00p ET 09/22/23
  • Last (size)
    1
  • 52-Wk Range
    6.73 - 16.28
    LowHigh
  • (01/06/23 - 09/21/23)
    3.86%
  • 69.5%
  • Market Cap
    196.0M
  • Shares Outstanding
    28.0M
  • -2.43
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.9
  • 90.74
  • (% of float 08/31/23)
    3.44

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.